CompletedNCT05772221
Official study titleThe Role of Social Determinants in Cardiovascular Health and Vascular Function in a Racial and Ethnic Minority Population at High Risk for Disparities
This study has finished and is no longer accepting participants.
In DallasDepressionInterventional studyAges 18+
- Countries
- United States
- Sponsor
- Baylor Research Institute
CompletedNCT02907476
This study has finished and is no longer accepting participants.
In BostonDepression, PTSD, ...Behavioural studyAges 18–65
- Countries
- United States
- Sponsor
- Boston University
CompletedNCT03053362
Official study titleAn Open-Label Clinical Trial Evaluating Sensitivity to Change in Cognition Using the THINC-it Following Treatment With Vortioxetine in Major Depressive Disorder
This study has finished and is no longer accepting participants.
In TorontoDepressionMedication studyAges 18–65
- Countries
- Canada
- Sponsor
- Brain and Cognition Discovery Foundation
CompletedNCT00869765
Official study titleAn Open Pilot Trial of Transcranial Direct Current Stimulation (tDCS) Augmented by D-Cycloserine as a Treatment for Depression.
This study has finished and is no longer accepting participants.
In RandwickDepression, BipolarityMedication studyAges 18–90
- Countries
- Australia
- Sponsor
- The University of New South Wales
CompletedNCT06518642
This study has finished and is no longer accepting participants.
In Hong KongDepressionDevice studyAges 16–25
- Countries
- China
- Sponsor
- The University of Hong Kong
CompletedNCT02809677
This study has finished and is no longer accepting participants.
In DallasDepressionInterventional studyAges 7–70
- Countries
- United States
- Sponsor
- University of Texas Southwestern Medical Center
CompletedNCT04392947
This study has finished and is no longer accepting participants.
Multiple locations, including AugsburgDepressionDevice studyAges 18–70
- Countries
- Germany
- Sponsor
- University Hospital Tuebingen
CompletedNCT05536414
What is this study about?This study evaluated the safety and effectiveness of Centanafadine for people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including YumaDepressionMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
CompletedNCT03302611
Official study titleA Randomized Controlled Trial of Surf and Hike Therapy for Active-duty Service Members With Major Depressive Disorder
This study has finished and is no longer accepting participants.
In San DiegoDepressionBehavioural studyAges 18+
- Countries
- United States
- Sponsor
- United States Naval Medical Center, San Diego
CompletedNCT04891224
Official study titleImplementation and Evaluation of the Pathway Platform: A Digitally Enabled Care Pathway to Improve Depression Key Performance Indicators and Patient Outcomes in Primary Care Clinics
This study has finished and is no longer accepting participants.
In Oak LawnDepressionInterventional studyAges 18+
- Countries
- United States
- Sponsor
- Wake Forest University Health Sciences
CompletedNCT06920238
Official study titleA Phase I Single-Arm Trial to Test the Use of a Generative AI (Gen-AI) Chatbot for Anxiety and Depression Among Persons With Cannabis Use Disorder (CUD)
This study has finished and is no longer accepting participants.
In LebanonDepression, Anxiety, ...Device studyAges 18+
- Countries
- United States
- Sponsor
- Trustees of Dartmouth College
CompletedNCT06402422
Official study titleVulnerability Markers for Depression: a Concurrent TMS-fNIRS Study
This study has finished and is no longer accepting participants.
In Hong KongDepressionObservational studyAges 18–65
- Countries
- China
- Sponsor
- The Hong Kong Polytechnic University